Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017

11.15.2017 By Ecaterina Craciun

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Wednesday said it registered sales revenue of RON234 million in January-September 2017, up 3% from the year-earlier period, and its net profit rose 14% to RON20.24 million.



To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 25 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:
Antibiotice Iasi
, results

Please fill all required fields!

Your comment was successfully added!

Comments will appear only after the moderation.